Correspondence 0001437749-26-005619 from PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC.
Date: Feb. 25, 2026 · CIK: 0001625101 · Accession: 0001437749-26-005619
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293596
Letter
plse20260225_corresp.htm
PULSE BIOSCIENCES, INC.
601 Brickell Key Drive, Suite 1080
Miami, Florida 33131
(510) 906-4600
February 25, 2026
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Pulse Biosciences, Inc. Registration Statement on Form S-3 File No. 333-293596 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “ Act ”), Pulse Biosciences, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-293596) (the “ Registration Statement ”), so that it may become effective at 4:00 p.m. Eastern time on February 27, 2026 or as soon thereafter as practicable, unless we or our outside counsel, Baker & Hostetler LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Registrant acknowledges that it is aware of its obligations under the Act.
We request that we be notified of such effectiveness by a telephone call to Adam Finerman, of Baker & Hostetler LLP, at (212) 589-4233 or by email at afinerman@bakerlaw.com.
[ Remainder of this page is intentionally left blank ]
Very truly yours,
PULSE BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm plse20260225_corresp.htm PULSE BIOSCIENCES, INC. 601 Brickell Key Drive, Suite 1080 Miami, Florida 33131 (510) 906-4600 February 25, 2026 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Pulse Biosciences, Inc. Registration Statement on Form S-3 File No. 333-293596 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “ Act ”), Pulse Biosciences, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-293596) (the “ Registration Statement ”), so that it may become effective at 4:00 p.m. Eastern time on February 27, 2026 or as soon thereafter as practicable, unless we or our outside counsel, Baker & Hostetler LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Registrant acknowledges that it is aware of its obligations under the Act. We request that we be notified of such effectiveness by a telephone call to Adam Finerman, of Baker & Hostetler LLP, at (212) 589-4233 or by email at afinerman@bakerlaw.com. [ Remainder of this page is intentionally left blank ] Very truly yours, PULSE BIOSCIENCES, INC. By: /s/ Kenneth B. Stratton Name: Kenneth B. Stratton Title: General Counsel